We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Microrheological Method Determines Blood Type

By LabMedica International staff writers
Posted on 13 Aug 2013
The development of microfluidic blood-typing assays can reduce the time of analysis, and enable simultaneous determination of the most clinically important antigens. More...


A method for typing and subtyping blood has been developed in a simple microfluidic system that monitors the speed of flow of microdroplets and determining agglutination in small samples of liquid.

Scientists at the Institute of Physical Chemistry of the Polish Academy of Sciences (Warsaw, Poland) have demonstrated a microfluidic method for reproducible and objective determination of agglutination in small, nanoliter quantities of liquid. They demonstrated the reliability of the method on the model example of determination of blood type, yet the method should also be possible to use with the wide range of agglutination assays used in in vitro diagnostics.

The investigators tested agglutination in droplets with A, B and O blood groups, and then a second series of agglutination test in droplets with different Rh factors. Each series was performed for both standardized red blood cells and human blood samples. The red blood cells were not removed from the whole blood before these tests. In each series a droplet with antibodies was linked in the merging chamber with a droplet containing red blood cells. The merging chamber was equipped with two electrodes connected to a source of alternating current (AC) electrostatic potential. An oscillating electric field speeds up the coalescence of droplets arriving from the individual T-junctions. A created droplet was sent to the section of measurement for the time of flow.

The method had a very high sensitivity and reliability. The reliability approached 100% with an estimated chance of mistyping on the order of one per million samples. The method of detection of agglutination could potentially be used for automating various agglutination assays. The authors noted that the method offers the potential benefits of a reduction of the volume of blood sample to single microliters for the whole test, the lack of requirement for preprocessing such as centrifugation, and eliminating any subjectivity from the procedure.

Importantly, the method could be compliant both with a point-of-care format for the simplest blood-typing protocols and with multiplexed assays for complex analyses, such as cross-match testing or other multiple antigen determinations in a bench-top format. The study was published on June 18, 2013, in the journal Lab on a Chip.

Related Links:
Polish Institute of Physical Chemistry


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Neonatal Heel Incision Device
Tenderfoot
New
Alzheimer's Disease Biomarker Assay
Elecsys Phospho-Tau (217P) Plasma
Urine Analyzer
respons® UDS100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Lead author Professor Chamindie Punyadeera. (Image Credit: Griffith University)

Breath Analysis Shows Promise for Distinguishing Cancerous from Benign Lung Nodules

Lung nodules are frequently detected during imaging, but distinguishing malignant from benign findings can require invasive procedures. Some patients undergo biopsies, bronchoscopy, or surgery before learning... Read more

Molecular Diagnostics

view channel
Image: Skin samples from people with a suspected genetic myopathy were examined for confirmation of disease. Brown spots show abnormal protein buildup inside the nuclei of cells (purple), typical of a type of myopathy called oculopharyngodistal myopathy. (Image Credit: Garvan Institute)

Long-Read Sequencing Test Identifies Genetic Causes in Inherited Muscle Disease

Inherited muscle diseases are highly heterogeneous and often progressive, leaving many patients without a molecular diagnosis despite extensive testing. Conventional assays typically target individual... Read more

Immunology

view channel
Image: Aptiva utilizes particle-based multi-analyte technology (PMAT) (Photo courtesy of Werfen)

Werfen Expands Automated APS Testing with FDA-Cleared and CE-Marked IgA Reagent

Antiphospholipid syndrome (APS) is an autoimmune disorder associated with thrombosis and pregnancy complications, but its symptoms can overlap with those of other conditions, complicating diagnosis.... Read more

Microbiology

view channel
Image: Each PhAST instrument supports random-access processing of up to four samples simultaneously, delivering a throughput of up to 12 samples per eight-hour shift. (Photo courtesy of PhAST)

FDA Clears Rapid Phenotypic Antimicrobial Susceptibility System for Positive Blood Cultures

Bloodstream infections require prompt treatment, but antimicrobial susceptibility results often lag behind a positive blood culture. Conventional testing can take another 24 to 48 hours after a culture... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.